Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 114 citing articles:

LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing
Qi Wen Chen, Qian Qian Cai, Ying Yang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Therapeutic potential of extracellular vesicle‐associated long noncoding RNA
Louis J. Born, John W. Harmon, Steven M. Jay
Bioengineering & Translational Medicine (2020) Vol. 5, Iss. 3
Open Access | Times Cited: 47
Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark
Shanshan Zhao, Xue Zhang, Shuo Chen, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 46
Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia
Li Qiu, Gan Zhou, Shan Cao
Life Sciences (2019) Vol. 243, pp. 117234-117234
Open Access | Times Cited: 45
LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca2+-FAK signal pathway
Ke Pan, Yong Xie
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 44
Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer
Peng Yang, Dihong Tang, Meng Zhao, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 3, pp. 825-835
Closed Access | Times Cited: 44
The network of non-coding RNAs and their molecular targets in breast cancer
Francesca Crudele, Nicoletta Bianchi, Eva Reali, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
MAFG‐AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma
Mengqing Xiao, Jianye Liu, Liang Xiang, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 8
Open Access | Times Cited: 41
Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
Meenakshi Sudhakaran, Andrea I. Doseff
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5086-5086
Open Access | Times Cited: 16
The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis
Huilin Zhang, Bingjian Lŭ
Cancers (2020) Vol. 12, Iss. 10, pp. 2926-2926
Open Access | Times Cited: 38
LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway
Shuang Qiu, Guobing Chen, Juan Peng, et al.
FEBS Open Bio (2020) Vol. 10, Iss. 5, pp. 817-826
Open Access | Times Cited: 37
Integrative analysis of circRNAs, miRNAs, and mRNAs profiles to reveal ceRNAs networks in chicken intramuscular and abdominal adipogenesis
Meng Zhang, Yu Han, Yanhui Zhai, et al.
BMC Genomics (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Exosome-Derived LncRNAs in Lung Cancer
Tao Fan, Nan Sun, Jie He
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 34
Non-coding RNAs in breast cancer: Implications for programmed cell death
Yan Luo, Weiqiang Tang, Shasha Xiang, et al.
Cancer Letters (2022) Vol. 550, pp. 215929-215929
Closed Access | Times Cited: 20
H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy
Chenming Zhong, Zijun Xie, Shiwei Duan
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 12
Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer
Chaojun Zhu, Yihong Lai, Chengdong Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Investigate of LOC101928988 Regulatory Effect on the DAPK2 Transcription in Breast Tumors
Mohammadreza Saberiyan, Nazila Ghasemi, Negar Jafari, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients
Tomasz Kolenda, Piotr Białas, Kacper Guglas, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 798-798
Open Access
The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mechanisms and Potential of Antitumor Therapy With Natural Products Regulating Non‐Coding RNAs
Zhuguo Wang, Fei Wang, Huiming Huang, et al.
Phytotherapy Research (2025)
Closed Access
The LncRNA RMST-miR-4295-ITPR1 axis: a key mechanism in regulating autophagy in triple-negative breast cancer cells
Linlei Zhang, Sainan Li, Jiajie Shi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Non-coding RNAs and lipids mediate the function of extracellular vesicles in cancer cross-talk
Ai Kotani, Masatoshi Ito, Kai Kudo
Seminars in Cancer Biology (2021) Vol. 74, pp. 121-133
Open Access | Times Cited: 26
A Novel Cellular Senescence-related lncRNA Signature for Predicting the Prognosis of Breast Cancer Patients
Fangxu Yin, Wenhao Zhao, Chen Ding, et al.
Journal of Cancer (2024) Vol. 15, Iss. 14, pp. 4700-4716
Open Access | Times Cited: 3
Breast Cancer Stem Cell-Derived ANXA6-Containing Exosomes Sustain Paclitaxel Resistance and Cancer Aggressiveness in Breast Cancer
Zihe Guo, Ayao Guo, Chuang Zhou
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22

Scroll to top